nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—Autonomic neuropathy—Cisplatin—esophageal cancer	0.0245	0.0464	CcSEcCtD
Eplerenone—Prothrombin level decreased—Capecitabine—esophageal cancer	0.0214	0.0405	CcSEcCtD
Eplerenone—Angina unstable—Capecitabine—esophageal cancer	0.0162	0.0307	CcSEcCtD
Eplerenone—Coronary artery disease—Cisplatin—esophageal cancer	0.0141	0.0266	CcSEcCtD
Eplerenone—Serum creatinine increased—Cisplatin—esophageal cancer	0.00904	0.0171	CcSEcCtD
Eplerenone—Sudden death—Capecitabine—esophageal cancer	0.00801	0.0152	CcSEcCtD
Eplerenone—Hydrocortisone—ANXA1—esophageal cancer	0.00745	0.269	CrCbGaD
Eplerenone—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00714	0.0135	CcSEcCtD
Eplerenone—Infection—Carboplatin—esophageal cancer	0.00672	0.0127	CcSEcCtD
Eplerenone—Serum creatinine increased—Capecitabine—esophageal cancer	0.00666	0.0126	CcSEcCtD
Eplerenone—Hypothyroidism—Capecitabine—esophageal cancer	0.00638	0.0121	CcSEcCtD
Eplerenone—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00625	0.0118	CcSEcCtD
Eplerenone—Hyperuricaemia—Cisplatin—esophageal cancer	0.00599	0.0113	CcSEcCtD
Eplerenone—Sudden death—Methotrexate—esophageal cancer	0.00596	0.0113	CcSEcCtD
Eplerenone—Pain—Carboplatin—esophageal cancer	0.00578	0.0109	CcSEcCtD
Eplerenone—Blood uric acid increased—Cisplatin—esophageal cancer	0.00566	0.0107	CcSEcCtD
Eplerenone—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00554	0.0105	CcSEcCtD
Eplerenone—Hyperkalaemia—Cisplatin—esophageal cancer	0.00546	0.0103	CcSEcCtD
Eplerenone—Body temperature increased—Carboplatin—esophageal cancer	0.00535	0.0101	CcSEcCtD
Eplerenone—Proteinuria—Capecitabine—esophageal cancer	0.00466	0.00883	CcSEcCtD
Eplerenone—Protein urine present—Capecitabine—esophageal cancer	0.0046	0.00871	CcSEcCtD
Eplerenone—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00454	0.00859	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00451	0.00853	CcSEcCtD
Eplerenone—Hyponatraemia—Cisplatin—esophageal cancer	0.00405	0.00767	CcSEcCtD
Eplerenone—Influenza like illness—Capecitabine—esophageal cancer	0.00398	0.00753	CcSEcCtD
Eplerenone—Blood creatinine increased—Cisplatin—esophageal cancer	0.00378	0.00716	CcSEcCtD
Eplerenone—Dehydration—Cisplatin—esophageal cancer	0.00375	0.00711	CcSEcCtD
Eplerenone—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00369	0.00698	CcSEcCtD
Eplerenone—Hypokalaemia—Cisplatin—esophageal cancer	0.00367	0.00695	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00363	0.00688	CcSEcCtD
Eplerenone—Spironolactone—ABCC2—esophageal cancer	0.00348	0.126	CrCbGaD
Eplerenone—Proteinuria—Methotrexate—esophageal cancer	0.00347	0.00657	CcSEcCtD
Eplerenone—Protein urine present—Methotrexate—esophageal cancer	0.00342	0.00648	CcSEcCtD
Eplerenone—Diabetes mellitus—Capecitabine—esophageal cancer	0.00342	0.00647	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00336	0.00635	CcSEcCtD
Eplerenone—Hyperuricaemia—Methotrexate—esophageal cancer	0.00329	0.00623	CcSEcCtD
Eplerenone—Libido decreased—Capecitabine—esophageal cancer	0.00321	0.00607	CcSEcCtD
Eplerenone—Atrial fibrillation—Capecitabine—esophageal cancer	0.00314	0.00594	CcSEcCtD
Eplerenone—Renal impairment—Capecitabine—esophageal cancer	0.00313	0.00592	CcSEcCtD
Eplerenone—Blood uric acid increased—Methotrexate—esophageal cancer	0.00311	0.00588	CcSEcCtD
Eplerenone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00307	0.0058	CcSEcCtD
Eplerenone—Renal failure—Cisplatin—esophageal cancer	0.00306	0.00579	CcSEcCtD
Eplerenone—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00305	0.00577	CcSEcCtD
Eplerenone—Myocardial infarction—Cisplatin—esophageal cancer	0.00305	0.00577	CcSEcCtD
Eplerenone—Hyponatraemia—Capecitabine—esophageal cancer	0.00299	0.00565	CcSEcCtD
Eplerenone—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00295	0.00559	CcSEcCtD
Eplerenone—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00294	0.00557	CcSEcCtD
Eplerenone—Methyltestosterone—CYP19A1—esophageal cancer	0.00289	0.104	CrCbGaD
Eplerenone—Blood creatinine increased—Capecitabine—esophageal cancer	0.00279	0.00528	CcSEcCtD
Eplerenone—Dehydration—Capecitabine—esophageal cancer	0.00277	0.00524	CcSEcCtD
Eplerenone—Urinary tract disorder—Cisplatin—esophageal cancer	0.00276	0.00522	CcSEcCtD
Eplerenone—Connective tissue disorder—Cisplatin—esophageal cancer	0.00274	0.00519	CcSEcCtD
Eplerenone—Urethral disorder—Cisplatin—esophageal cancer	0.00274	0.00518	CcSEcCtD
Eplerenone—Gynaecomastia—Methotrexate—esophageal cancer	0.00273	0.00517	CcSEcCtD
Eplerenone—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00272	0.00514	CcSEcCtD
Eplerenone—Pulmonary oedema—Methotrexate—esophageal cancer	0.00272	0.00514	CcSEcCtD
Eplerenone—Hypokalaemia—Capecitabine—esophageal cancer	0.00271	0.00513	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00268	0.00507	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00262	0.00497	CcSEcCtD
Eplerenone—Tinnitus—Cisplatin—esophageal cancer	0.0026	0.00493	CcSEcCtD
Eplerenone—Cardiac disorder—Cisplatin—esophageal cancer	0.00259	0.00491	CcSEcCtD
Eplerenone—Flushing—Cisplatin—esophageal cancer	0.00259	0.00491	CcSEcCtD
Eplerenone—Diabetes mellitus—Methotrexate—esophageal cancer	0.00255	0.00482	CcSEcCtD
Eplerenone—Mediastinal disorder—Cisplatin—esophageal cancer	0.00252	0.00476	CcSEcCtD
Eplerenone—Angina pectoris—Capecitabine—esophageal cancer	0.0025	0.00474	CcSEcCtD
Eplerenone—Bronchitis—Capecitabine—esophageal cancer	0.00247	0.00468	CcSEcCtD
Eplerenone—Malnutrition—Cisplatin—esophageal cancer	0.00243	0.0046	CcSEcCtD
Eplerenone—Progesterone—CYP1B1—esophageal cancer	0.00242	0.0873	CrCbGaD
Eplerenone—Flatulence—Cisplatin—esophageal cancer	0.00239	0.00453	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00239	0.00452	CcSEcCtD
Eplerenone—Muscle spasms—Cisplatin—esophageal cancer	0.00234	0.00442	CcSEcCtD
Eplerenone—Hyperglycaemia—Capecitabine—esophageal cancer	0.00232	0.00439	CcSEcCtD
Eplerenone—Pneumonia—Capecitabine—esophageal cancer	0.00231	0.00437	CcSEcCtD
Eplerenone—Infestation NOS—Capecitabine—esophageal cancer	0.00229	0.00434	CcSEcCtD
Eplerenone—Infestation—Capecitabine—esophageal cancer	0.00229	0.00434	CcSEcCtD
Eplerenone—Depression—Capecitabine—esophageal cancer	0.00229	0.00433	CcSEcCtD
Eplerenone—Testosterone—CYP1B1—esophageal cancer	0.00228	0.0826	CrCbGaD
Eplerenone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00226	0.00428	CcSEcCtD
Eplerenone—Ill-defined disorder—Cisplatin—esophageal cancer	0.00226	0.00427	CcSEcCtD
Eplerenone—Renal failure—Capecitabine—esophageal cancer	0.00225	0.00427	CcSEcCtD
Eplerenone—Myocardial infarction—Capecitabine—esophageal cancer	0.00225	0.00425	CcSEcCtD
Eplerenone—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00225	0.00425	CcSEcCtD
Eplerenone—Anaemia—Cisplatin—esophageal cancer	0.00225	0.00425	CcSEcCtD
Eplerenone—Urinary tract infection—Capecitabine—esophageal cancer	0.00223	0.00422	CcSEcCtD
Eplerenone—Malaise—Cisplatin—esophageal cancer	0.00219	0.00415	CcSEcCtD
Eplerenone—Haematuria—Capecitabine—esophageal cancer	0.00219	0.00414	CcSEcCtD
Eplerenone—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00217	0.0041	CcSEcCtD
Eplerenone—Drospirenone—PTGS2—esophageal cancer	0.00212	0.0765	CrCbGaD
Eplerenone—Myalgia—Cisplatin—esophageal cancer	0.00207	0.00392	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00205	0.00389	CcSEcCtD
Eplerenone—Hypoaesthesia—Capecitabine—esophageal cancer	0.00205	0.00388	CcSEcCtD
Eplerenone—Discomfort—Cisplatin—esophageal cancer	0.00204	0.00387	CcSEcCtD
Eplerenone—Pharyngitis—Capecitabine—esophageal cancer	0.00204	0.00387	CcSEcCtD
Eplerenone—Urinary tract disorder—Capecitabine—esophageal cancer	0.00203	0.00385	CcSEcCtD
Eplerenone—Oedema peripheral—Capecitabine—esophageal cancer	0.00203	0.00384	CcSEcCtD
Eplerenone—Connective tissue disorder—Capecitabine—esophageal cancer	0.00202	0.00383	CcSEcCtD
Eplerenone—Urethral disorder—Capecitabine—esophageal cancer	0.00202	0.00382	CcSEcCtD
Eplerenone—Infection—Cisplatin—esophageal cancer	0.00197	0.00373	CcSEcCtD
Eplerenone—Nervous system disorder—Cisplatin—esophageal cancer	0.00195	0.00368	CcSEcCtD
Eplerenone—Skin disorder—Cisplatin—esophageal cancer	0.00193	0.00365	CcSEcCtD
Eplerenone—Tinnitus—Capecitabine—esophageal cancer	0.00192	0.00363	CcSEcCtD
Eplerenone—Hyperhidrosis—Cisplatin—esophageal cancer	0.00192	0.00363	CcSEcCtD
Eplerenone—Cardiac disorder—Capecitabine—esophageal cancer	0.00191	0.00362	CcSEcCtD
Eplerenone—Flushing—Capecitabine—esophageal cancer	0.00191	0.00362	CcSEcCtD
Eplerenone—Eosinophilia—Methotrexate—esophageal cancer	0.0019	0.00359	CcSEcCtD
Eplerenone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00189	0.00427	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00189	0.00425	CbGpPWpGaD
Eplerenone—Angiopathy—Capecitabine—esophageal cancer	0.00187	0.00353	CcSEcCtD
Eplerenone—Progesterone—CYP2A6—esophageal cancer	0.00186	0.0673	CrCbGaD
Eplerenone—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00186	0.00419	CbGpPWpGaD
Eplerenone—Mediastinal disorder—Capecitabine—esophageal cancer	0.00185	0.00351	CcSEcCtD
Eplerenone—Hypotension—Cisplatin—esophageal cancer	0.00185	0.00351	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP19A1—esophageal cancer	0.00184	0.00414	CbGpPWpGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00184	0.00413	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00181	0.00408	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00181	0.00408	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00181	0.00342	CcSEcCtD
Eplerenone—Mental disorder—Capecitabine—esophageal cancer	0.0018	0.00341	CcSEcCtD
Eplerenone—Malnutrition—Capecitabine—esophageal cancer	0.00179	0.00339	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00179	0.00402	CbGpPWpGaD
Eplerenone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00178	0.00337	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00177	0.004	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00177	0.004	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—ADH7—esophageal cancer	0.00177	0.00399	CbGpPWpGaD
Eplerenone—Dyspnoea—Cisplatin—esophageal cancer	0.00177	0.00335	CcSEcCtD
Eplerenone—Flatulence—Capecitabine—esophageal cancer	0.00177	0.00334	CcSEcCtD
Eplerenone—Back pain—Capecitabine—esophageal cancer	0.00173	0.00328	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00173	0.00389	CbGpPWpGaD
Eplerenone—Muscle spasms—Capecitabine—esophageal cancer	0.00172	0.00326	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—esophageal cancer	0.00172	0.00325	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00171	0.00324	CcSEcCtD
Eplerenone—Infestation—Methotrexate—esophageal cancer	0.00171	0.00323	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—esophageal cancer	0.00171	0.00323	CcSEcCtD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.0017	0.00384	CbGpPWpGaD
Eplerenone—Depression—Methotrexate—esophageal cancer	0.0017	0.00322	CcSEcCtD
Eplerenone—Pain—Cisplatin—esophageal cancer	0.0017	0.00321	CcSEcCtD
Eplerenone—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00169	0.00382	CbGpPWpGaD
Eplerenone—Renal failure—Methotrexate—esophageal cancer	0.00168	0.00318	CcSEcCtD
Eplerenone—Testosterone—CYP19A1—esophageal cancer	0.00168	0.0606	CrCbGaD
Eplerenone—Ill-defined disorder—Capecitabine—esophageal cancer	0.00166	0.00315	CcSEcCtD
Eplerenone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00166	0.00374	CbGpPWpGaD
Eplerenone—Anaemia—Capecitabine—esophageal cancer	0.00166	0.00313	CcSEcCtD
Eplerenone—Feeling abnormal—Cisplatin—esophageal cancer	0.00163	0.00309	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—esophageal cancer	0.00163	0.00308	CcSEcCtD
Eplerenone—Malaise—Capecitabine—esophageal cancer	0.00162	0.00306	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00161	0.00306	CcSEcCtD
Eplerenone—Syncope—Capecitabine—esophageal cancer	0.00161	0.00304	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00158	0.00356	CbGpPWpGaD
Eplerenone—Loss of consciousness—Capecitabine—esophageal cancer	0.00157	0.00298	CcSEcCtD
Eplerenone—Body temperature increased—Cisplatin—esophageal cancer	0.00157	0.00297	CcSEcCtD
Eplerenone—Cough—Capecitabine—esophageal cancer	0.00156	0.00296	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00156	0.00351	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—ADH1B—esophageal cancer	0.00155	0.0035	CbGpPWpGaD
Eplerenone—Chest pain—Capecitabine—esophageal cancer	0.00153	0.00289	CcSEcCtD
Eplerenone—Arthralgia—Capecitabine—esophageal cancer	0.00153	0.00289	CcSEcCtD
Eplerenone—Myalgia—Capecitabine—esophageal cancer	0.00153	0.00289	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—esophageal cancer	0.00152	0.00288	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00151	0.00287	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—esophageal cancer	0.00151	0.00286	CcSEcCtD
Eplerenone—Discomfort—Capecitabine—esophageal cancer	0.00151	0.00285	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—esophageal cancer	0.0015	0.00284	CcSEcCtD
Eplerenone—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.0015	0.00337	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00149	0.00335	CbGpPWpGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00147	0.0033	CbGpPWpGaD
Eplerenone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00146	0.00329	CbGpPWpGaD
Eplerenone—Infection—Capecitabine—esophageal cancer	0.00145	0.00275	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—CYP26A1—esophageal cancer	0.00144	0.00325	CbGpPWpGaD
Eplerenone—Shock—Capecitabine—esophageal cancer	0.00144	0.00272	CcSEcCtD
Eplerenone—Nervous system disorder—Capecitabine—esophageal cancer	0.00143	0.00271	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—esophageal cancer	0.00143	0.0027	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00142	0.00321	CbGpPWpGaD
Eplerenone—Asthenia—Cisplatin—esophageal cancer	0.00142	0.00269	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—esophageal cancer	0.00142	0.00269	CcSEcCtD
Eplerenone—Skin disorder—Capecitabine—esophageal cancer	0.00142	0.00269	CcSEcCtD
Eplerenone—Hyperhidrosis—Capecitabine—esophageal cancer	0.00141	0.00268	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.0014	0.00315	CbGpPWpGaD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00139	0.00313	CbGpPWpGaD
Eplerenone—Angiopathy—Methotrexate—esophageal cancer	0.00139	0.00263	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—esophageal cancer	0.00138	0.00261	CcSEcCtD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00137	0.00309	CbGpPWpGaD
Eplerenone—Hypotension—Capecitabine—esophageal cancer	0.00137	0.00259	CcSEcCtD
Eplerenone—Diarrhoea—Cisplatin—esophageal cancer	0.00136	0.00257	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—esophageal cancer	0.00134	0.00254	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTO1—esophageal cancer	0.00134	0.00302	CbGpPWpGaD
Eplerenone—Malnutrition—Methotrexate—esophageal cancer	0.00133	0.00252	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00133	0.00252	CcSEcCtD
Eplerenone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00133	0.00299	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00133	0.00299	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTO1—esophageal cancer	0.00132	0.00298	CbGpPWpGaD
Eplerenone—Insomnia—Capecitabine—esophageal cancer	0.00132	0.0025	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00131	0.00295	CbGpPWpGaD
Eplerenone—Dyspnoea—Capecitabine—esophageal cancer	0.0013	0.00247	CcSEcCtD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00129	0.00291	CbGpPWpGaD
Eplerenone—Back pain—Methotrexate—esophageal cancer	0.00129	0.00244	CcSEcCtD
Eplerenone—Dyspepsia—Capecitabine—esophageal cancer	0.00129	0.00244	CcSEcCtD
Eplerenone—Spironolactone—ABCB1—esophageal cancer	0.00128	0.0463	CrCbGaD
Eplerenone—CYP3A5—Biological oxidations—ADH7—esophageal cancer	0.00128	0.00288	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00127	0.00287	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00126	0.00239	CcSEcCtD
Eplerenone—Vomiting—Cisplatin—esophageal cancer	0.00126	0.00239	CcSEcCtD
Eplerenone—Fatigue—Capecitabine—esophageal cancer	0.00126	0.00239	CcSEcCtD
Eplerenone—Rash—Cisplatin—esophageal cancer	0.00125	0.00237	CcSEcCtD
Eplerenone—Pain—Capecitabine—esophageal cancer	0.00125	0.00237	CcSEcCtD
Eplerenone—Constipation—Capecitabine—esophageal cancer	0.00125	0.00237	CcSEcCtD
Eplerenone—Dermatitis—Cisplatin—esophageal cancer	0.00125	0.00237	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—esophageal cancer	0.00124	0.00234	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—esophageal cancer	0.00123	0.00233	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—SMG6—esophageal cancer	0.00121	0.00272	CbGpPWpGaD
Eplerenone—Feeling abnormal—Capecitabine—esophageal cancer	0.0012	0.00228	CcSEcCtD
Eplerenone—Malaise—Methotrexate—esophageal cancer	0.0012	0.00228	CcSEcCtD
Eplerenone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.0012	0.00226	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.00119	0.00269	CbGpPWpGaD
Eplerenone—Nausea—Cisplatin—esophageal cancer	0.00118	0.00223	CcSEcCtD
Eplerenone—Cough—Methotrexate—esophageal cancer	0.00116	0.0022	CcSEcCtD
Eplerenone—Abdominal pain—Capecitabine—esophageal cancer	0.00116	0.00219	CcSEcCtD
Eplerenone—Body temperature increased—Capecitabine—esophageal cancer	0.00116	0.00219	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—esophageal cancer	0.00114	0.00215	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—esophageal cancer	0.00114	0.00215	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—esophageal cancer	0.00114	0.00215	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00113	0.00254	CbGpPWpGaD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00113	0.00213	CcSEcCtD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00113	0.00254	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—ADH1B—esophageal cancer	0.00112	0.00253	CbGpPWpGaD
Eplerenone—Discomfort—Methotrexate—esophageal cancer	0.00112	0.00212	CcSEcCtD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00112	0.00252	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00111	0.0025	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00111	0.0025	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—ALDH2—esophageal cancer	0.00109	0.00246	CbGpPWpGaD
Eplerenone—Infection—Methotrexate—esophageal cancer	0.00108	0.00205	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.00107	0.00241	CbGpPWpGaD
Eplerenone—Nervous system disorder—Methotrexate—esophageal cancer	0.00107	0.00202	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00106	0.00239	CbGpPWpGaD
Eplerenone—Skin disorder—Methotrexate—esophageal cancer	0.00106	0.002	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00106	0.00238	CbGpPWpGaD
Eplerenone—Hyperhidrosis—Methotrexate—esophageal cancer	0.00105	0.00199	CcSEcCtD
Eplerenone—Asthenia—Capecitabine—esophageal cancer	0.00105	0.00199	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—CYP26A1—esophageal cancer	0.00104	0.00235	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTT1—esophageal cancer	0.00104	0.00234	CbGpPWpGaD
Eplerenone—Pruritus—Capecitabine—esophageal cancer	0.00103	0.00196	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00103	0.00232	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP2A6—esophageal cancer	0.00103	0.00232	CbGpPWpGaD
Eplerenone—Hypotension—Methotrexate—esophageal cancer	0.00102	0.00193	CcSEcCtD
Eplerenone—Diarrhoea—Capecitabine—esophageal cancer	0.001	0.00189	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000992	0.00188	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—SLC52A3—esophageal cancer	0.000988	0.00222	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—BLVRB—esophageal cancer	0.000988	0.00222	CbGpPWpGaD
Eplerenone—Insomnia—Methotrexate—esophageal cancer	0.000984	0.00186	CcSEcCtD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000982	0.00221	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—PTGS1—esophageal cancer	0.000975	0.0022	CbGpPWpGaD
Eplerenone—Dyspnoea—Methotrexate—esophageal cancer	0.00097	0.00184	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTO1—esophageal cancer	0.00097	0.00218	CbGpPWpGaD
Eplerenone—Dizziness—Capecitabine—esophageal cancer	0.000967	0.00183	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—esophageal cancer	0.000958	0.00181	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTO1—esophageal cancer	0.000957	0.00215	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00094	0.00178	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—esophageal cancer	0.000938	0.00178	CcSEcCtD
Eplerenone—Pain—Methotrexate—esophageal cancer	0.000931	0.00176	CcSEcCtD
Eplerenone—Vomiting—Capecitabine—esophageal cancer	0.00093	0.00176	CcSEcCtD
Eplerenone—Rash—Capecitabine—esophageal cancer	0.000922	0.00175	CcSEcCtD
Eplerenone—Dermatitis—Capecitabine—esophageal cancer	0.000921	0.00174	CcSEcCtD
Eplerenone—Headache—Capecitabine—esophageal cancer	0.000916	0.00173	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—NR1I2—esophageal cancer	0.000916	0.00206	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000913	0.00206	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000899	0.00203	CbGpPWpGaD
Eplerenone—Feeling abnormal—Methotrexate—esophageal cancer	0.000897	0.0017	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00089	0.00168	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000883	0.00199	CbGpPWpGaD
Eplerenone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000881	0.00198	CbGpPWpGaD
Eplerenone—Nausea—Capecitabine—esophageal cancer	0.000869	0.00164	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—esophageal cancer	0.00086	0.00163	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—esophageal cancer	0.00086	0.00163	CcSEcCtD
Eplerenone—Hydrocortisone—ABCB1—esophageal cancer	0.000851	0.0308	CrCbGaD
Eplerenone—CYP11B2—Metabolism—CA1—esophageal cancer	0.00084	0.00189	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SLC10A2—esophageal cancer	0.00084	0.00189	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000839	0.00189	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP1B1—esophageal cancer	0.000829	0.00187	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000818	0.00184	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000803	0.00181	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.0008	0.0018	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000792	0.00178	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—ALDH2—esophageal cancer	0.000791	0.00178	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—HIST1H2BM—esophageal cancer	0.000785	0.00177	CbGpPWpGaD
Eplerenone—Asthenia—Methotrexate—esophageal cancer	0.000781	0.00148	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—CYP19A1—esophageal cancer	0.000779	0.00176	CbGpPWpGaD
Eplerenone—Pruritus—Methotrexate—esophageal cancer	0.00077	0.00146	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000769	0.00173	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CA2—esophageal cancer	0.000768	0.00173	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000752	0.00169	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTT1—esophageal cancer	0.000752	0.00169	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000751	0.00169	CbGpPWpGaD
Eplerenone—Diarrhoea—Methotrexate—esophageal cancer	0.000745	0.00141	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—CYP2A6—esophageal cancer	0.000743	0.00167	CbGpPWpGaD
Eplerenone—Dizziness—Methotrexate—esophageal cancer	0.00072	0.00136	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—PLCE1—esophageal cancer	0.000714	0.00161	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ADH7—esophageal cancer	0.000714	0.00161	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000706	0.00159	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—PTGS1—esophageal cancer	0.000705	0.00159	CbGpPWpGaD
Eplerenone—Progesterone—ABCB1—esophageal cancer	0.000694	0.0251	CrCbGaD
Eplerenone—Vomiting—Methotrexate—esophageal cancer	0.000692	0.00131	CcSEcCtD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000692	0.00156	CbGpPWpGaD
Eplerenone—Rash—Methotrexate—esophageal cancer	0.000686	0.0013	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—esophageal cancer	0.000686	0.0013	CcSEcCtD
Eplerenone—Headache—Methotrexate—esophageal cancer	0.000682	0.00129	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000663	0.00149	CbGpPWpGaD
Eplerenone—Testosterone—ABCB1—esophageal cancer	0.000656	0.0237	CrCbGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000651	0.00147	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000647	0.00146	CbGpPWpGaD
Eplerenone—Nausea—Methotrexate—esophageal cancer	0.000647	0.00122	CcSEcCtD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000638	0.00144	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ADH1B—esophageal cancer	0.000626	0.00141	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000617	0.00139	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PSME1—esophageal cancer	0.000609	0.00137	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PSME2—esophageal cancer	0.000609	0.00137	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000608	0.00137	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000601	0.00135	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.0006	0.00135	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP1B1—esophageal cancer	0.000599	0.00135	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—TYMP—esophageal cancer	0.000598	0.00135	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000595	0.00134	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000591	0.00133	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP26A1—esophageal cancer	0.000582	0.00131	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NOTCH3—esophageal cancer	0.000575	0.00129	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALOX15—esophageal cancer	0.000567	0.00128	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000563	0.00127	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000556	0.00125	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—TPI1—esophageal cancer	0.000541	0.00122	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTO1—esophageal cancer	0.000541	0.00122	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000524	0.00118	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000522	0.00117	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALDOB—esophageal cancer	0.000519	0.00117	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NOTCH2—esophageal cancer	0.000516	0.00116	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GAPDH—esophageal cancer	0.000499	0.00112	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CRABP1—esophageal cancer	0.000495	0.00111	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000493	0.00111	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000485	0.00109	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000478	0.00108	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GNG7—esophageal cancer	0.000471	0.00106	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000451	0.00102	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000445	0.001	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALDH2—esophageal cancer	0.000441	0.000993	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—SMAD4—esophageal cancer	0.000433	0.000975	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTT1—esophageal cancer	0.00042	0.000945	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC52A3—esophageal cancer	0.000419	0.000943	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—BLVRB—esophageal cancer	0.000419	0.000943	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP2A6—esophageal cancer	0.000415	0.000934	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000413	0.00093	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS1—esophageal cancer	0.000393	0.000885	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ENO1—esophageal cancer	0.000393	0.000885	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PSME2—esophageal cancer	0.000387	0.000872	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PSME1—esophageal cancer	0.000387	0.000872	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000368	0.000828	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—MYC—esophageal cancer	0.000357	0.000803	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CA1—esophageal cancer	0.000356	0.000802	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.000356	0.000802	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00035	0.000787	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000346	0.000778	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000338	0.000762	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP1B1—esophageal cancer	0.000334	0.000753	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000328	0.000738	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CA2—esophageal cancer	0.000326	0.000733	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NOTCH1—esophageal cancer	0.000319	0.000719	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP19A1—esophageal cancer	0.000314	0.000708	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000303	0.000682	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000303	0.000682	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000303	0.000682	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000303	0.000682	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—CREBBP—esophageal cancer	0.000289	0.000652	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—HMOX1—esophageal cancer	0.000287	0.000646	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000281	0.000634	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000279	0.000627	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ABCB1—esophageal cancer	0.000275	0.00062	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000275	0.000619	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000266	0.000598	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000262	0.00059	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000258	0.000582	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CA1—esophageal cancer	0.000257	0.00058	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000257	0.00058	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000254	0.000571	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000247	0.000556	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000241	0.000542	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CA2—esophageal cancer	0.000235	0.00053	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TPI1—esophageal cancer	0.000229	0.000517	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.000229	0.000517	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.00022	0.000495	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000219	0.000493	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000219	0.000493	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000212	0.000477	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.00021	0.000473	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000208	0.000469	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GNG7—esophageal cancer	0.0002	0.00045	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000192	0.000432	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.000187	0.000421	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CREBBP—esophageal cancer	0.000184	0.000414	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000183	0.000413	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000178	0.000402	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000178	0.000401	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000176	0.000396	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000174	0.000392	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MYC—esophageal cancer	0.000172	0.000387	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000167	0.000375	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000167	0.000375	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000166	0.000374	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000166	0.000374	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NOS3—esophageal cancer	0.000165	0.000371	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000164	0.00037	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000164	0.00037	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000159	0.000358	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000153	0.000345	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000152	0.000342	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS2—esophageal cancer	0.000151	0.000339	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000144	0.000325	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.000142	0.000319	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000141	0.000317	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000141	0.000317	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000135	0.000304	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP19A1—esophageal cancer	0.000133	0.0003	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000129	0.00029	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.000127	0.000286	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—EP300—esophageal cancer	0.000125	0.000282	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HMOX1—esophageal cancer	0.000122	0.000274	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000121	0.000271	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000121	0.000271	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CA1—esophageal cancer	0.00012	0.000269	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.00012	0.000269	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PSME2—esophageal cancer	0.000119	0.000267	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PSME1—esophageal cancer	0.000119	0.000267	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ABCB1—esophageal cancer	0.000117	0.000263	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CA2—esophageal cancer	0.000109	0.000246	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP1B1—esophageal cancer	0.000102	0.000231	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000102	0.000229	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000102	0.000229	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP19A1—esophageal cancer	9.63e-05	0.000217	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CA—esophageal cancer	9.27e-05	0.000209	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.92e-05	0.000201	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HMOX1—esophageal cancer	8.79e-05	0.000198	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TYMP—esophageal cancer	8.53e-05	0.000192	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ABCB1—esophageal cancer	8.44e-05	0.00019	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	8.29e-05	0.000187	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALOX15—esophageal cancer	8.08e-05	0.000182	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CREBBP—esophageal cancer	7.8e-05	0.000176	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.71e-05	0.000174	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TPI1—esophageal cancer	7.71e-05	0.000174	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALDOB—esophageal cancer	7.39e-05	0.000166	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GAPDH—esophageal cancer	7.12e-05	0.00016	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CRABP1—esophageal cancer	7.05e-05	0.000159	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NOS3—esophageal cancer	6.99e-05	0.000157	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GNG7—esophageal cancer	6.71e-05	0.000151	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS2—esophageal cancer	6.39e-05	0.000144	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALDH2—esophageal cancer	6.29e-05	0.000142	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.98e-05	0.000135	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.91e-05	0.000133	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CREBBP—esophageal cancer	5.64e-05	0.000127	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.6e-05	0.000126	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ENO1—esophageal cancer	5.6e-05	0.000126	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PSME1—esophageal cancer	5.52e-05	0.000124	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PSME2—esophageal cancer	5.52e-05	0.000124	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—EP300—esophageal cancer	5.31e-05	0.00012	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NOS3—esophageal cancer	5.05e-05	0.000114	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.76e-05	0.000107	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS2—esophageal cancer	4.62e-05	0.000104	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.48e-05	0.000101	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.09e-05	9.2e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.93e-05	8.85e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.92e-05	8.83e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—EP300—esophageal cancer	3.84e-05	8.65e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.84e-05	6.4e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.62e-05	5.9e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NOS3—esophageal cancer	2.35e-05	5.29e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.15e-05	4.84e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—EP300—esophageal cancer	1.79e-05	4.02e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.32e-05	2.97e-05	CbGpPWpGaD
